Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9749889 | 0.83 | — | — | |
| SCHEMBL1054328 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL10944341 | 0.81 | — | — | |
| SCHEMBL9191057 | 0.81 | — | — | |
| SCHEMBL9076215 | 0.81 | — | — | |
| Bromide SCHEMBL9435928 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL10656294 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL7527399 | 0.78 | — | — | |
| SCHEMBL7063422 | 0.76 | — | — | |
| SCHEMBL10878067 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018230-A1 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018230-A1 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | IFNG, TNF, IL2 | ALDH1A1 4548/4885CYP2C9 4147/4885HPGD 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.